SCHEMBL3976246

SCHEMBL3976246

NCCCC[C@@H]([C]=O)NC(=O)CCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
THRB P10828 2/20 0.52
KMT2A Q03164 2/20 0.52
ALDH1A1 P00352 2/20 0.52
MEN1 O00255 1/20 0.52
PLG P00747 1/20 0.52
ALOX15 P16050 1/20 0.52
SLC6A2 P23975 1/20 0.52
RECQL P46063 1/20 0.52
SLC6A3 Q01959 1/20 0.52
CYP2D6 P10635 1/20 0.48
NFKB1 P19838 1/20 0.48
BLM P54132 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
FOLH1 Q04609 2/20 0.44
SLC6A5 Q9Y345 1/20 0.44
NMT1 P30419 5/20 0.41
NMT2 O60551 4/20 0.41
GABRR3 A8MPY1 1/20 0.41
GABRP O00591 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27535723 0.94 SLC6A5 (0.45) LMNATHRBKMT2AALDH1A1MEN1
SCHEMBL3717425 0.94 SLC6A5 (0.45) LMNATHRBKMT2AALDH1A1MEN1
SCHEMBL2182070 0.89 SLC6A5 (0.40) LMNATHRBKMT2AALDH1A1MEN1
SCHEMBL3758242 0.87 SLC6A5 (0.55) KMT2AMEN1SLC6A5PLA2G2CPLA2G10
SCHEMBL8846585 0.87 SLC6A5 (0.55) KMT2AMEN1SLC6A5PLA2G2CPLA2G10
SCHEMBL25183394 0.85 PLA2G2C (0.49) LMNAKMT2AMEN1CYP2D6NFKB1
SCHEMBL25173449 0.85 PLA2G2C (0.49) LMNAKMT2AMEN1CYP2D6NFKB1
SCHEMBL25186456 0.85 PLA2G2C (0.49) LMNAKMT2AMEN1CYP2D6NFKB1
SCHEMBL7186702 0.85 SLC6A5 (0.53) KMT2AMEN1SLC6A5PLA2G2CPLA2G10
SCHEMBL3628190 0.84 KMT2A (0.46) LMNATHRBKMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217621-B1 INSULIN DERIVATIVE NOVO NORDISK AS (DK) 2015-04-22 EP disclosed
EP-2058330-A1 Insulin derivative NOVO NORDISK A/S (DK) 2009-05-13 EP disclosed